The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

LifePoint Hospitals Inc

Nasdaq: LPNT
Last

(U.S.) $72.20

Today's change+2.85 +4.11%
Updated December 18 4:15 PM EST. Delayed by at least 15 minutes.
 

LifePoint Hospitals Inc

Nasdaq: LPNT
Last

(U.S.) $72.20

Today's change+2.85 +4.11%
Updated December 18 4:15 PM EST. Delayed by at least 15 minutes.

LifePoint Hospitals Inc crosses above 20-day moving average

LifePoint Hospitals Inc closed up sharply Thursday, rallying (U.S.)$2.85 or 4.11% to (U.S.)$72.20 and crossing above its 20-day moving average. Shares have lost 0.41% over the last five days, but have gained 36.64% over the last year to date. This security has outperformed the S&P 500 by 27.84% during the last year.

Key company metrics

  • Open(U.S.) $70.76
  • Previous close(U.S.) $69.35
  • High(U.S.) $72.22
  • Low(U.S.) $70.19
  • Bid / Ask(U.S.) $62.57 / (U.S.) $78.00
  • YTD % change+36.64%
  • Volume368,019
  • Average volume (10-day)382,223
  • Average volume (1-month)355,382
  • Average volume (3-month)493,552
  • 52-week range(U.S.) $49.65 to (U.S.) $76.50
  • Beta0.99
  • Trailing P/E24.38×
  • P/E 1 year forward22.34×
  • Forward PEG1.49×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.96
Updated December 18 4:15 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.50%

Based on its net profit margin of 3.50%, LifePoint Hospitals Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.93%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,1661,0471,007953
Total other revenue--------
Total revenue1,1661,0471,007953
Gross profit427396375355
Total cost of revenue739651632598
Total operating expense1,120981956891
Selling / general / administrative243222211200
Research & development--------
Depreciation / amortization69616159
Interest expense (income), net operating--------
Unusual expense (income)120--1
Other operating expenses, total2815197
Operating income46675162
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax46675162
Income after tax29423838
Income tax, total17251324
Net income28393736
Total adjustments to net income--------
Net income before extra. items28393736
Minority interest-1-3-1-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items28393736
Inc. avail. to common incl. extra. items28393736
Diluted net income28393736
Dilution adjustment0------
Diluted weighted average shares47474848
Diluted EPS excluding extraordinary itemsvalue per share0.590.840.780.75
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.750.840.780.77